Salvage PRRT with 177Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival - Concepedia

Concepedia

Publication | Open Access

Salvage PRRT with 177Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival

DOI Full Paper Access

79

Citations

25

References

2019

Year

Simon Rudisile, Astrid Gosewisch, Vera Wenter, Marcus Unterrainer, Guido Böning, Franz Josef Gildehaus, Wolfgang P. Fendler, Christoph J. Auernhammer, Christine Spitzweg, Peter Bartenstein,

Abstract

Salvage therapy with <sup>177</sup>Lu-DOTATATE is safe and effective even in patients with extensive previous multimodal therapies during disease progression and represents a feasible and valuable therapy option for progressive NET.

References

	Year	Citations

Page 1